Everence Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,580
| Closed | -$219 | – | 758 |
|
|
2022
Q4 | $219 | Buy |
+18,580
| New | +$219 | 0.02% | 661 |
|
|
2022
Q3 | – | Sell |
-8,680
| Closed | -$269K | – | 728 |
|
|
2022
Q2 | $269K | Hold |
8,680
| – | – | 0.02% | 554 |
|
|
2022
Q1 | $356K | Hold |
8,680
| – | – | 0.03% | 507 |
|
|
2021
Q4 | $377K | Buy |
+8,680
| New | +$377K | 0.03% | 515 |
|
|
2020
Q3 | – | Sell |
-7,680
| Closed | -$641K | – | 694 |
|
|
2020
Q2 | $641K | Hold |
7,680
| – | – | 0.08% | 218 |
|
|
2020
Q1 | $444K | Buy |
7,680
+1,180
| +18% | +$68.2K | 0.06% | 269 |
|
|
2019
Q4 | $351K | Hold |
6,500
| – | – | 0.05% | 425 |
|
|
2019
Q3 | $340K | Hold |
6,500
| – | – | 0.06% | 388 |
|
|
2019
Q2 | $314K | Hold |
6,500
| – | – | 0.05% | 418 |
|
|
2019
Q1 | $328K | Buy |
6,500
+2,540
| +64% | +$128K | 0.06% | 376 |
|
|
2018
Q4 | $235K | Hold |
3,960
| – | – | 0.05% | 339 |
|
|
2018
Q3 | $261K | Buy |
+3,960
| New | +$261K | 0.05% | 350 |
|
|
2018
Q2 | – | Sell |
-3,960
| Closed | -$208K | – | 432 |
|
|
2018
Q1 | $208K | Buy |
+3,960
| New | +$208K | 0.05% | 386 |
|